A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...

A refined liquid biopsy that accounts for age-related background mutations has enabled clinicians to identify patients with non-muscle invasive bladder cancer who could benefit from ...

Research at Stanford Medicine suggests that a urine test may. be able to determine which patients will benefit from additional therapy.

In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for ...

A new study from Stanford researchers reveals a non-invasive urine test that can accurately detect residual bladder cancer ...

A urinary DNA methylation test demonstrated high sensitivity and specificity for detecting high-grade or invasive bladder cancer, outperforming both nuclear matrix protein 22 (NMP22) and urine ...

Researchers from the University of Birmingham’s Bladder Cancer Research Centre have used a new method to detect chemical changes in the DNA in an individual’s urine sample - epigenetic changes, called ...

Please provide your email address to receive an email when new articles are posted on . A urinary DNA methylation test outperformed the nuclear matrix protein 22 test or urine cytology test.

A noninvasive urinary DNA methylation test demonstrated high sensitivity for detecting high-grade or invasive bladder cancer. A urinary DNA methylation test displayed superior sensitivity for ...

Precision Diagnostics today announced the publication of its latest whitepaper, "Use of Short Tandem Repeats (STR) for the Identification and Verification of Urine Specimens," introducing a novel, DNA ...